Shandong Teamgene Technology Co. Ltd. A (603151) — Capital Reinvestment Ratio

Latest as of December 2022: 2.92x

Shandong Teamgene Technology Co. Ltd. A (603151) has a Capital Reinvestment Ratio of 2.92x as of December 2022, meaning it reinvests 3% of its operating cash flow (CN¥59.07 Million) in capital expenditures (CN¥172.41 Million). Check 603151 tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

2.92x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥59.07 Million
CNY

Capital Expenditures

CN¥172.41 Million
CNY

Data as of

Dec 2022
Most recent filing

Shandong Teamgene Technology Co. Ltd. A Capital Reinvestment Ratio (2020–2022)

This chart tracks Shandong Teamgene Technology Co. Ltd. A's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see 603151 cash generation efficiency.

Annual Capital Reinvestment Ratio for Shandong Teamgene Technology Co. Ltd. A (2020–2022)

Year-by-year Capital Reinvestment Ratio for Shandong Teamgene Technology Co. Ltd. A from 2020 to 2022. See 603151 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2022 2.92x CN¥59.07 Million CN¥172.41 Million ▲ +294.4%
2021 0.74x CN¥131.51 Million CN¥97.31 Million ▲ +443.7%
2020 0.14x CN¥169.11 Million CN¥23.02 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow